The Texas Medical Association Applauds Trump Appointment to HHS

Translate to Spanish or other 102 languages!

Rep. Tom Price (R-Ga.), a veteran lawmaker and vehement critic of the Affordable Care Act, has been picked as President-elect Donald Trump's choice to lead the Department of Health and Human Services.
Rep. Tom Price (R-Ga.), a veteran lawmaker and vehement critic of the Affordable Care Act, has been picked as President-elect Donald Trump’s choice to lead the Department of Health and Human Services.

Mega Doctor News

- Advertisement -

Statement by Texas Medical Association (TMA) President Don R. Read, MD, on President-Elect Donald Trump’s announcement that he will appoint U.S. Rep. Tom Price, MD, of Georgia as secretary of the Department of Health and Human Services (HHS).

“The physicians of Texas are extremely pleased by President-Elect Donald Trump’s announcement this morning that he will appoint Rep. Tom Price, an orthopedic surgeon, to be the new U.S. secretary of health and human services.

“Dr. Price is a problem-solver by nature, and he is committed to addressing many intractable problems that get in the way of physicians caring for our patients. For years, he has targeted government programs like the Physician Quality Reporting System and the misnamed meaningful use program. These and many other federal regulations are no more than paper-pushing exercises that do nothing to improve quality of care.

- Advertisement -

“We look forward to working with Dr. Price to clear away these time-sucking obstacles to good patient care.”

TMA is the largest state medical society in the nation, representing more than 49,000 physician and medical student members. It is located in Austin and has 110 component county medical societies around the state. TMA’s key objective since 1853 is to improve the health of all Texans.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

New FDA Nexus NAIN Targets Breakthrough Treatments for Brain and Nervous System Disorders

The U.S. Food and Drug Administration today announced the launch of the Neuroscience Advancement and Innovation Nexus (NAIN), a new agency program aligned with the Trump Administration’s efforts to accelerate medical innovation and deliver breakthrough treatments.

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

Dr. Lisa Chapa Explains Why Not Every Breast Lump Is Cancer

 Discovering a lump in the breast can cause immediate concern, but many breast abnormalities are not cancerous, according to Dr. Lisa Chapa, a breast surgeon who explained how physicians distinguish benign conditions from breast cancer.

DHR Health Expands Behavioral Health Team with Dr. Alexandra Treviño, Psychiatrist

 DHR Health, the largest provider of specialty healthcare in the Rio Grande Valley, is pleased to announce that Dr. Alexandra Treviño, has joined its team of physicians.
- Advertisement -